✦ LIBER ✦

Recombinant human interleukin-3 in refractory severe aplastic anaemia: a phase I/II trial

✍ Scribed by Mario J. Bargetzi; Eliane Gldckman; Andre Tichelli; Agnes Devergie; Helene Esperou; Janusz Kabata; Alexandra Wodnar-Filipowicz; Catherine Nissen; Bruno Speck; Alois Gratwohl

Book ID: 114714242
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 695 KB
Volume: 91
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb05294.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A trial of recombinant human interleukin

A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemia

✍ Christopher E. Walsh; Johnson M. Liu; Stacie M. Anderson; Jeffrey L. Rossio; Art 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB

A phase I/II study of recombinant human

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C

✍ Stefan Zeuzem; Uwe Hopf; Vicente Carreno; Moisés Diago; Mitchell Shiffman; Stefa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Medullary histiocytosis following treatm

Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone

✍ F. Herrmann; A. Lindemann; W. Lange; G. Köchling; A. Raghavachar; H. Schrezenmei 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 649 KB

A Phase I Dose-Finding Trial of Recombin

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

✍ Timmerman, J. M.; Byrd, J. C.; Andorsky, D. J.; Yamada, R. E.; Kramer, J.; Muthu 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 371 KB

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

Prospective randomized open-label multic

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

✍ Daniel C. Baumgart; Stephan R. Targan; Axel U. Dignass; Lloyd Mayer; Gert van As 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Background: Visilizumab is a humanized igg(2) monoclonal anti-cd3 antibody. we evaluated its safety and dose response in severe intravenous steroid-refractory ulcerative colitis (uc). ## Methods: In all, 104 patients were treated. in stage i, 73 patients were randomly assigned to receive intra